Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

908 Devices (MASS) Common Equity (2020 - 2025)

908 Devices (MASS) has disclosed Common Equity for 6 consecutive years, with $143.7 million as the latest value for Q4 2025.

  • Quarterly Common Equity rose 25.4% to $143.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $143.7 million through Dec 2025, up 25.4% year-over-year, with the annual reading at $143.7 million for FY2025, 25.4% up from the prior year.
  • Common Equity for Q4 2025 was $143.7 million at 908 Devices, up from $136.3 million in the prior quarter.
  • The five-year high for Common Equity was $214.6 million in Q4 2021, with the low at $114.6 million in Q4 2024.
  • Average Common Equity over 5 years is $161.5 million, with a median of $158.2 million recorded in 2024.
  • The sharpest move saw Common Equity soared 301.7% in 2021, then tumbled 30.76% in 2024.
  • Over 5 years, Common Equity stood at $214.6 million in 2021, then decreased by 11.19% to $190.6 million in 2022, then fell by 13.17% to $165.5 million in 2023, then tumbled by 30.76% to $114.6 million in 2024, then rose by 25.4% to $143.7 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $143.7 million, $136.3 million, and $148.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.